Literature DB >> 17000015

Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders?

C Sue Carter1.   

Abstract

Autism spectrum disorders (ASD) are male-biased and characterized by deficits in social behavior and social communication, excessive anxiety or hyperreactivity to stressful experiences, and a tendency toward repetitiveness. The purpose of this review is to consider evidence for a role for two sexually dimorphic neuropeptides, oxytocin (OT) and arginine vasopressin (VP), in these features of ASD. Both VP and OT play a role in normal development. VP is androgen-dependent and of particular importance to male behavior. Excess VP or disruptions in the VP system could contribute to the male vulnerability to ASD. Alternatively, protective processes mediated via OT or the OT receptor might help to explain the relatively rare occurrence of ASD in females. Disruptions in either OT or VP or their receptors could result from genetic variation or epigenetic modifications of gene expression, especially during early development. Deficits in other developmental growth factors, such as reelin, which may in turn regulate or be regulated by OT or VP, are additional candidates for a role in ASD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000015     DOI: 10.1016/j.bbr.2006.08.025

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  117 in total

Review 1.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

Review 2.  Consequences of early experiences and exposure to oxytocin and vasopressin are sexually dimorphic.

Authors:  C Sue Carter; Ericka M Boone; Hossein Pournajafi-Nazarloo; Karen L Bales
Journal:  Dev Neurosci       Date:  2009-06-17       Impact factor: 2.984

3.  Sexual differentiation of vasopressin innervation of the brain: cell death versus phenotypic differentiation.

Authors:  Geert J de Vries; Michelle Jardon; Mohammed Reza; Greta J Rosen; Eleanor Immerman; Nancy G Forger
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

4.  Specifying the neurobiological basis of human attachment: brain, hormones, and behavior in synchronous and intrusive mothers.

Authors:  Shir Atzil; Talma Hendler; Ruth Feldman
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

5.  The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice.

Authors:  Panos Zanos; Polymnia Georgiou; Sherie R Wright; Susanna M Hourani; Ian Kitchen; Raphaëlle Winsky-Sommerer; Alexis Bailey
Journal:  Neuropsychopharmacology       Date:  2013-10-15       Impact factor: 7.853

6.  Perceived Intensity of Emotional Point-Light Displays is Reduced in Subjects with ASD.

Authors:  Britta Krüger; Morten Kaletsch; Sebastian Pilgramm; Sven-Sören Schwippert; Jürgen Hennig; Rudolf Stark; Stefanie Lis; Bernd Gallhofer; Gebhard Sammer; Karen Zentgraf; Jörn Munzert
Journal:  J Autism Dev Disord       Date:  2018-01

7.  Parental oxytocin and early caregiving jointly shape children's oxytocin response and social reciprocity.

Authors:  Ruth Feldman; Ilanit Gordon; Moran Influs; Tamar Gutbir; Richard P Ebstein
Journal:  Neuropsychopharmacology       Date:  2013-01-16       Impact factor: 7.853

8.  Fibroblast growth factor 2 alters the oxytocin receptor in a developmental model of anxiety-like behavior in male rat pups.

Authors:  Yoav Litvin; Cortney A Turner; Mariel B Rios; Pamela M Maras; Sraboni Chaudhury; Miriam R Baker; Peter Blandino; Stanley J Watson; Huda Akil; Bruce McEwen
Journal:  Horm Behav       Date:  2016-09-28       Impact factor: 3.587

9.  Variation of the oxytocin/neurophysin I (OXT) gene in four human populations.

Authors:  Yang Xu; Yali Xue; Allan Daly; Lijie Wu; Chris Tyler-Smith
Journal:  J Hum Genet       Date:  2008-06-20       Impact factor: 3.172

Review 10.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.